SERPINE1 and type 2 diabetes mellitus: Mechanisms dependent on the inhibitor of plasminogen activator (PAI-1) encoded by SERPINE-1 are involved in the pathogenesis of obesity, IR, and T2D [60], and methylation levels of SERPINE-1 have been associated with obesity and metabolic syndrome [48].